InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
T+90 hit rate
0%
T+90 mean return
-12.1%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by PIMSTONE SIMON N., Chief Executive Officer. Insider active across 2 companies, notably Xenon Pharmaceuticals Inc.. Cumulatively, 9 reports have been recorded. Breakdown: 0 buy · 5 sells. Total volume traded: €3.3m. Activity tracked since 24 May 2021. The latest transaction was disclosed on 30 May 2023 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
18,006 shares@ US$38.6327.7% of flowCommon SharesSEC:0000950170-23-025802:0
41,152 shares@ US$2.684.4% of flowCommon SharesSEC:0001209191-23-017636:0
43,135 shares@ US$37.9167.8% of flowCommon SharesSEC:0001209191-22-046015:0
10,288 shares@ US$3.670.0006% mcap2.8% of flowCommon SharesSEC:0001209191-22-017341:0
2,500 shares@ US$30.800.0013% mcap5.9% of flowCommon SharesSEC:0001209191-22-017418:0
17,557 shares@ US$31.3339.9% of flowCommon SharesSEC:0001209191-21-064931
17,557 shares@ US$31.330.0091% mcap39.9% of flowCommon SharesSEC:0001209191-21-064931:0
22,633 shares@ US$3.760.0013% mcap5.8% of flowCommon SharesSEC:0001209191-21-035911:0
22,633 shares@ US$3.765.8% of flowCommon SharesSEC:0001209191-21-035911
9 of 9 declarations
About PIMSTONE SIMON N.
Simon N. Pimstone is the CEO and Director at Xenon Pharmaceuticals Inc. He leads the company in the pharmaceutical sector, focusing on developing innovative treatments. His leadership is essential in guiding the strategy and growth of the company.
